AI-generated summary
The authors report a prospective study of 76 oncology patients with oral mucositis, randomly split into four groups of 19 receiving Intravenous Laser Irradiation of Blood alone or combined with low-level laser therapy. The combined treatment groups showed greater reductions in mucositis grade and quality-of-life scores than the blood irradiation alone groups. The study is described as quasi-experimental, so the authors' conclusions are limited by its design.
- Participants
- 76
- Who or what was studied
- Oncology patients with oral mucositis from antineoplastic therapy, treated at the Memorial Hospital of Arcoverde (PE) between 2023 and 2024
- Limits stated in the abstract
- The abstract describes a quasi-experimental design, and the abstract does not report wavelengths, dosing or follow-up duration.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Photobiomodulation, Laser, Low-level laser therapy, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.